Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women

Haematologica

Volumn 105, Issue 5, 2020, Pages 1232-1239

  Stoffel, Nicole U ^a   Zeder, Christophe ^a   Brittenham, Gary M ^b   Moretti, Diego ^a   Zimmermann, Michael B ^a  

^a ETH ZURICH   (Switzerland)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FERROUS SULFATE; GLYCOPHORIN A; HEMOGLOBIN; HEPCIDIN; IRON; OROSOMUCOID; TRANSFERRIN;

ADULT; ARTICLE; BLOOD DONOR; BODY MASS; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DIARRHEA; EPIGASTRIC PAIN; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; IRON ABSORPTION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; MORNING DOSAGE; NAUSEA; PROTEIN EXPRESSION; SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VOMITING; DIETARY SUPPLEMENT; SWITZERLAND;

ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; FEMALE; HEPCIDINS; HUMANS; IRON; SWITZERLAND;

EID: 85086041430     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/HAEMATOL.2019.220830     Document Type: Article

References (30)

1. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014; 123(5):615-624.
2. Cogswell ME, Looker AC, Pfeiffer CM, et al. Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006. Am J Clin Nutr. 2009;89(5):1334-1342.
3. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol. 2005;18(2):319-332.
4. Camaschella C. Iron deficiency: new insights into diagnosis and treatment. Hematology Am Soc Hematol Educ Program. 2015;2015:8-13.
5. CDC. Recommendations to Prevent and Control Iron Deficiency in the United States. Atlanta: Centers for Disease Control and Prevention (CDC). 1998 [cited 2018 21.09]; Available from: https://www.cdc.gov/mmwr/preview/mm wrhtml/00051880.htm
6. Stoltzfus RJ, Dreyfuss ML. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia: International Nutritional Anemia Consultative Group (INACG), 1998. Available from: motherchildnutrition. org/nutrition-protection-promotion/ pdf/mcn-guidelines-for-iron-supplementation. pdf
7. Pavord S, Myers B, Robinson S, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012; 156(5):588-600.
8. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;22;126(17):1981-1989.
9. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal sideeffects in adults: a systematic review and meta-analysis. PloS One. 2015;10(2): e0117383.
10. Kortman GA, Raffatellu M, Swinkels DW, Tjalsma H. Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev 2014; 38(6):1202-1234
11. Lund EK, Fairweather-Tait SJ, Wharf SG, Johnson IT. Chronic exposure to high levels of dietary iron fortification increases lipid peroxidation in the mucosa of the rat large intestine. J Nutr. 2001;131(11):2928-2931.
12. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr. 1999;69(2):250-255.
13. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118(10):1142-1147.
14. Jaeggi T, Kortman GA, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731-742.
15. Paganini D, Uyoga MA, Kortman GAM, et al. Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants. Gut. 2017;66(11):1956-1967.
16. Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017;8(1):126-136.
17. Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11): e524-e533.
18. Schaap CC, Hendriks JC, Kortman GA, et al. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin Chem. 2013;59(3):527-535.
19. Troutt JS, Rudling M, Persson L, et al. Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration. Clin Chem. 2012;58(8):1225-1232.
20. Camaschella C. New insights into iron deficiency and iron deficiency anemia. Blood Rev. 2017;31(4):225-233.
21. Pena-Rosas JP, De-Regil LM, Gomez Malave H, Flores-Urrutia MC, Dowswell T. Intermittent oral iron supplementation during pregnancy. Cochrane DB Syst Rev. 2015 19(10):CD009997.
22. Pena-Rosas JP, Nesheim MC, Garcia-Casal MN, et al. Intermittent iron supplementation regimens are able to maintain safe maternal hemoglobin concentrations during pregnancy in Venezuela. J Nutr. 2004; 134(5):1099-1104.
23. Hotz K, Krayenbuehl PA, Walczyk T. Mobilization of storage iron is reflected in the iron isotopic composition of blood in humans. J Biol Inorg Chem. 2012;17(2):301-309.
24. Brown E, Bradley B, Wennesland R, Hodges JL, Hopper J, Yamauchi H. Red Cell, Plasma, and Blood Volume in Healthy Women Measured by Radichromium Cell- Labeling and Hematocrit. J Clin Invest. 1962;41:2182-2190.
25. Hosain F, Marsaglia G, Noyes W, Finch CA. The nature of internal iron exchange in man. Trans Assoc Am Physicians. 1962; 75:59-63.
26. Hallberg L. Combating iron deficiency: daily administration of iron is far superior to weekly administration. Am J Clin Nutr. 1998;68(2):213-217.
27. Zoller H, Koch RO, Theurl I, et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology. 2001;120(6): 1412-1419.
28. Stoffel NU, Zeder C, Fort E, Swinkels DW, Zimmermann MB, Moretti D. Prediction of human iron bioavailability using rapid c- ELISAs for human plasma hepcidin. Clin Chem Lab Med. 2017;26;55(8):1186-1192.
29. Maeda H, Hitomi Y, Hirata R, et al. The effect of phlebotomy on serum erythropoietin levels in normal healthy subjects. Int J Hematol. 1992;55(2):111-115.
30. Schotten N, Laarakkers CM, Roelofs RW, Origa R, van Kraaij MG, Swinkels DW. EPO and hepcidin plasma concentrations in blood donors and beta-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations. Am J Hematol. 2017;92(3):E29-E31.